Cyclosporin A--usefulness, risks and mechanism of action.
about
Differential effect of alpha-interferon and gamma-interferon on thromboplastin response in monocytes and endothelial cellsCyclosporine A: Novel concepts in its role in drug-induced gingival overgrowthNext-generation sequencing approach for connecting secondary metabolites to biosynthetic gene clusters in fungiEffect of cyclosporin A (CyA) on the immunopathological lesion of the labial minor salivary glands from patients with Sjögren's syndromeCyclosporin A inhibits smooth muscle proliferation in the vascular response to injury.Cyclosporine A-induced gingival hyperplasia pemphigus vulgaris: literature review and report of a case.Cyclosporine metabolism and pharmacokinetics following intravenous and oral administration in the dogThymic and lymphoid changes and serum immunoglobulin abnormalities in mice receiving cyclosporine.Severe systemic vascular necrosis in cyclosporin-treated rabbits with acute serum sicknessSelective suppression of an early step in human B cell activation by cyclosporin A.Effects of cyclosporin A on humoral immune response and resistance against vesicular stomatitis virus in mice.Brugia pahangi infections in immune-compromised rats demonstrate that separate mechanisms control adult worm and microfilarial numbers.Discovery of FK-506 and update.Immunomodulation by conditioning: recent developments.Differential effect of cyclosporin A on activation signaling in human T cell lines.Cyclosporine therapy. Its significance to the periodontist.Pathological changes in rats receiving cyclosporin A at immunotherapeutic dosage for 7 weeks.Periodontal changes in liver cirrhosis and post-transplantation patients. I: clinical findings.Prevalence and risk of gingival enlargement in patients treated with anticonvulsant drugs.Periodontal changes in liver cirrhosis and post-transplantation patients. II: radiographic findings:.Effect of cyclosporin a on normal, mitogen-stimulated and Marek's disease virus-exposed and transformed chicken lymphoid cells.Cyclosporine and dexamethasone inhibit T-lymphocyte MHC class II antigens and IL-2 receptor expression in experimental autoimmune uveitis.Differential inhibition by cyclosporin A reveals two pathways for activation of lymphokine synthesis in T cells.
P2860
Q24678286-47C619F3-010C-41D5-8C0D-BF1C7577E8FFQ26772184-F43BADC9-A94C-42B2-B951-F1E807311B0EQ28081722-AF4BC1EC-0E1D-4D38-AA07-0D6436F7AFAAQ33557218-64600323-0E79-4597-8775-57F1AAD7590DQ33564406-0D13C814-D1D3-4E96-A74C-11FCEC9C92BEQ33916257-309C6E27-C57A-4F97-B6F8-FA65DA63CD42Q34396798-09EC2392-66F9-4EAC-B7B1-BF78D77B17DCQ35856501-49A87A90-E29E-4D50-8553-AEC64C425872Q36090368-870FA2D0-515E-42DB-A37B-37D6613ACB7FQ36348079-EA4118CA-F27F-4BB4-8DAB-367CE019C1D4Q36860138-18510D14-9BE3-43E5-B89A-D6E5242C81AEQ39163613-D4BC0D12-4594-4F12-B472-D6C76BF80639Q40489665-B3546D70-C9B7-4962-8E57-BF3FEF172F78Q40862924-C8BFC804-EF86-4933-8EFF-F29C25F5B266Q40922766-E6F34175-0C81-4761-99BC-D8FA600586DCQ41411807-2B13EDAB-492D-428E-ADF2-35A320547BEFQ42614635-64647B9C-D1CB-488F-9AA3-8C8B60D918C6Q43751476-4EAE1D05-A976-40D7-ACE1-7B787CF32039Q43758702-8630DBFC-DDCE-4F47-8287-94FAAE68203DQ43939167-999607DD-5F89-45C3-9247-369B5D048821Q45391571-93D28F6C-9EBF-4191-A42F-B25AAEF9FDD3Q45443915-42A32883-DF55-4F15-9548-F4A8348D32B5Q46462469-5A7E7CC7-834F-4374-9DD1-BCC616EE4C56
P2860
Cyclosporin A--usefulness, risks and mechanism of action.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Cyclosporin A--usefulness, risks and mechanism of action.
@en
type
label
Cyclosporin A--usefulness, risks and mechanism of action.
@en
prefLabel
Cyclosporin A--usefulness, risks and mechanism of action.
@en
P2860
P1476
Cyclosporin A--usefulness, risks and mechanism of action.
@en
P2093
P2860
P356
10.1111/J.1600-065X.1982.TB00425.X
P577
1982-01-01T00:00:00Z